R
  • 773.714.0705
  • Home
  • About Us
  • Specialty
  • Activities
    • Live
    • Online
  • Outcomes & Toolkits
New User? Login
Certificate Use Certificate Code

Why Is the Unacceptable Acceptable? Pathways for Improved Screening and Early Diagnosis of Alpha1-Antitrypsin Deficiency (AATD)

Improving Screening and Early Diagnosis of Alpha-1 Antitrypsin Deficiency (AATD): Why Is the Unacceptable, Acceptable?
Improving Screening and Early Diagnosis of Alpha-1 Antitrypsin Deficiency (AATD): Why Is the Unacceptable, Acceptable?
Interactive Practice Guide

To facilitate the diagnosis and management of alpha-1 antitrypsin deficiency (AATD), clinicians require an understanding of the patient and clinical characteristics that should prompt screening, including a family history and signs of lung or liver involvement. This educational tool supports an easy translation of knowledge and encourages informed decision making for screening and testing patients for AATD. Access expert commentary, resources, and an animated video to be shared with patients who have a high probability of AATD, to increase awareness around common conditions related to AATD, how it is screened, and how to communicate with their healthcare team.

Faculty: Caroline Jouhourian, MD; Cheryl Pirozzi MD, MS

Release Date: February 24, 2023

Expiration Date: February 24, 2024

CME/CE is no longer available for this activity

footer-logo

308 S. Jefferson St.,
Suite 312,
Chicago, IL 60661

  • Phone: 773.714.0705
  • Fax: 773.714.0707
  • Home
  • Specialty
  • Sitemap
  • Privacy Policy
  • Contact Us
  • Follow us on Twitter
  • Like us on Facebook
  • Follow us on LinkedIn

Copyright © 2025 Academy for Continued Healthcare Learning. All Rights Reserved.

Processing...
×